Capital Research Global InvestorsCapital Research Global Investors

Institutional investor · Portfolio as of Q3 2020

Top Holdings405 positions

Checking export access…
Activity:

Microsoft Corp

94M$19.8B5.9%$95.58+109.27%
8 qtrssince 2018-Q4
Decreased
0

Netflix Inc

30.9M$15.4B4.6%$27.84+79.61%
8 qtrssince 2018-Q4
Decreased
0

Facebook Inc

54.7M$14.3B4.3%$132.14+96.31%
8 qtrssince 2018-Q4
Decreased
0

Amazon.com Inc

4M$12.7B3.8%$77.36+103.52%
8 qtrssince 2018-Q4
Decreased
0

Broadcom Inc

32.9M$12B3.6%$22.17+45.76%
8 qtrssince 2018-Q4
Increased
60

Abbott Laboratories

87.4M$9.5B2.9%$63.02+54.39%
8 qtrssince 2018-Q4
Decreased
0

Amgen Inc

33.5M$8.5B2.6%$156.83+34.76%
8 qtrssince 2018-Q4
Increased
55

Gilead Sciences Inc

117.1M$7.4B2.2%$51.73-2.08%
8 qtrssince 2018-Q4
Decreased
0

UnitedHealth Group Inc

22.2M$6.9B2.1%$227.85+23.23%
8 qtrssince 2018-Q4
Decreased
0

Mastercard Inc

17.4M$5.9B1.8%$199.42+63.84%
8 qtrssince 2018-Q4
Increased
55

Home Depot Inc/The

19M$5.3B1.6%$147.08+62.73%
8 qtrssince 2018-Q4
Decreased
0

Comcast Corp

112.7M$5.2B1.6%$31.10+14.51%
8 qtrssince 2018-Q4
Increased
72

Thermo Fisher Scientific Inc

11.6M$5.1B1.5%$219.16+98.20%
8 qtrssince 2018-Q4
Decreased
0

Alphabet Inc

3.3M$4.9B1.5%$53.16+36.56%
8 qtrssince 2018-Q4
Increased
53

Philip Morris International In

61.3M$4.6B1.4%$48.86+15.76%
8 qtrssince 2018-Q4
Increased
60

Alphabet Inc

2.8M$4.2B1.2%$52.55+38.52%
8 qtrssince 2018-Q4
Increased
50

CSX Corp

51.8M$4B1.2%$19.69+21.49%
8 qtrssince 2018-Q4
Increased
52

Apple Inc

34.5M$4B1.2%$48.97+129.19%
8 qtrssince 2018-Q4
Increased
81

AbbVie Inc

40.8M$3.6B1.1%$66.47+4.51%
8 qtrssince 2018-Q4
Decreased
0
13.9M$3.3B1.0%$153.33+43.37%
8 qtrssince 2018-Q4
Decreased
0
$333.1B
AUM
405
Positions
Q3 2020
Filing
HI score · 4.0/5
Quarterly 13F Value Change
-0%Q2'19$315B-3%Q3'19$304.9B+9%Q4'19$333.5B-24%Q1'20$254.9B+24%Q2'20$316.1B+5%Q3'20$333.1B
Activity profile
$ moved · Q3'20
New4%Increased46%Decreased48%Exited3%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.3 years
<1Q6%1-4Q19%1-2Y75%2Y+0%

Capital Research Global Investors manages $333.1B across 405 positions as of Q3 2020. Top holdings: MSFT (5.9%), NFLX (4.6%), META (4.3%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 4/5.0.

Q3 2020 Summary

Active quarter - 28 new positions, 22 exits, 162 increased. Top move: AAPL (INCREASED, conviction 81). Portfolio: $333.1B across 405 positions.

Top holdings by portfolio weight

Total AUM$333B
MSFT5.94%
NFLX4.64%
META4.30%
AMZN3.80%
AVGO3.59%
ABT2.86%
AMGN2.56%
GILD2.22%
UNH2.08%
MA1.76%
Other1.58%

Portfolio allocation by GICS sector

Sectors11
Healthcare18.62%
Technology18.31%
Communication Services14.75%
Consumer Cyclical12.58%
Industrials7.85%
Financial Services6.80%
Consumer Defensive6.13%
Energy3.53%
Utilities3.29%
Unknown3.23%
Other4.91%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Technology, Communication Services
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Strong(4.0 / 5.0)
Holdings P&L64
Conviction42
Concentration56
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
MOMOALTRIA GROUP INC
Q4 2024 → Q2 2026+46.6M shares+$3.6B
7Q
AEPAEPAMERICAN ELEC PWR CO INC
Q4 2024 → Q2 2026+62,748 shares+$58M
7Q
APHAPHAmphenol Corporation
Q4 2024 → Q2 2026+25.2M shares+$4.9B
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used